Indeed, especially in light of the significant challenge posed by this remarkable heterogeneity, we believe that our approach of identifying candidate master regulators, along with their relevant networks, by comparing initiating cells with their corresponding tumours further advances the functional reclassification of gliomas on the basis of physiopathologically meaningful TF-centred pathways. The gene discussed is TF; the disease is central nervous system cancer.